Why the study?
Does prophylactic aspirin provide benefit for the primary prevention of cardiovascular disease in healthy patients aged over 70?
Does prophylactic aspirin provide benefit for the primary prevention of cardiovascular disease in healthy patients aged over 70?
Clinicians should not use prophylactic aspirin for primary prevention in otherwise well patients aged over 70 due to lack of benefit and potential harm.
The tension between the benefits and harms of anticoagulation is finely balanced. Prophylactic aspirin in healthy, elderly patients provides no benefit and causes harm; clinicians should not use it for primary prevention in otherwise well patients aged over 70.
No takes yet. Share an insight, caveat, or question.
Jack W. O’Sullivan (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: